Skip to main content
Alembic Ltd logo

Alembic Ltd — Investor Relations & Filings

Ticker · ALEMBICLTD ISIN · INE426A01027 LEI · 9845006A8108YFEB5323 BSE.NS Manufacturing
Open in API
Filings indexed 1,554 across all filing types
Latest filing 2026-05-20 Regulatory Filings
Country IN India
Listing BSE.NS ALEMBICLTD

About Alembic Ltd

https://www.alembiclimited.com

Alembic Ltd is a long-standing pharmaceutical enterprise focused on the development, manufacturing, and marketing of generic pharmaceutical products and active pharmaceutical ingredients (APIs). Established in 1907, the company operates through a vertically integrated model, covering the entire value chain from research and development to commercial distribution. Its product portfolio spans several therapeutic areas, including anti-infectives, cardiovascular, gastrointestinal, and respiratory treatments. The organization maintains advanced manufacturing facilities and dedicated research centers to support its global supply chain. Alembic serves diverse international markets, providing high-quality formulations and bulk drugs to healthcare providers and partners. The company is recognized for its expertise in fermentation technology and its commitment to meeting international regulatory standards for pharmaceutical production.

Recent filings

Filing Released Lang Actions
General Updates
Regulatory Filings Classification · 82% confidence The document is an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) 2015 sent to the stock exchanges regarding reminder letters to shareholders about unclaimed dividends and transfer of shares to the Investor Education and Protection Fund. It is a regulatory disclosure under listing rules rather than a financial report, management commentary, or dividend declaration. This fits the fallback “Regulatory Filings” category (RNS).
2026-05-20 English
Please find enclosed herewith the specimen copy of the reminder letter sent to the shareholders of the Company informing them to claim their equity shares which otherwise are liable to ....
Regulatory Filings Classification · 88% confidence The document is an intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, disclosing a specimen reminder letter to shareholders regarding unclaimed dividends and the impending transfer of shares to the Investor Education and Protection Fund. This is a general regulatory announcement rather than a financial report, vote result, dividend declaration, or share issue notice. It falls under the broad “Regulatory Filings” category (RNS) as a Listing Regulation disclosure.
2026-05-20 English
Copy of Newspaper Publication
Report Publication Announcement Classification · 85% confidence The document is a regulatory disclosure to stock exchanges under SEBI LODR Regulations 30/47 announcing the publication of the company’s audited financial results via newspaper advertisements and providing a link/QR code to access the full report. It does not contain the full financial data itself but merely notifies investors that the report has been published externally. Under the “menu vs meal” rule, this is a Report Publication Announcement (RPA).
2026-05-20 English
Please find enclosed herewith newspaper cuttings related to advertisement published for Audited Financial Results of the Company for the Quarter and Financial Year ended on 31st March, 2026.
Report Publication Announcement Classification · 85% confidence The document is a short stock exchange disclosure under SEBI LODR Reg.30/47, enclosing newspaper cuttings of the Audited Financial Results advertisement and providing a QR code/link to the full results on the company website. It contains no actual financial statements or numerical data, only a notice that the report has been published. Under the “menu vs meal” rule, this is an announcement of the publication of a report, not the report itself. Therefore, it should be classified as a Report Publication Announcement (RPA).
2026-05-20 English
Please find enclosed results
Interim / Quarterly Report Classification · 85% confidence The document is a formal stock exchange filing detailing the Board meeting outcome, including the audited financial results for the quarter and full year ended 31 March 2026. It contains comprehensive financial statements (P&L, assets & liabilities, cash flows) and the statutory auditor’s report, not just a summary or link to a report. This matches the definition of an Interim/Quarterly Report (IR) under our taxonomy, since it presents substantive financial data for a period shorter than a full fiscal year (quarter plus year‐to‐date), rather than merely announcing or linking to a report. It is not a full Annual Report (10-K), nor just an Earnings Release (ER), but a detailed interim filing of results. FY 2026
2026-05-19 English
Dividend
Interim / Quarterly Report Classification · 88% confidence The document is a formal stock‐exchange filing from Alembic Limited notifying the outcome of its Board meeting, including the audited financial results for the quarter and year ended March 31, 2026, accompanied by full financial statements (income statement by quarter/year, segment data, assets & liabilities, cash flows) and the independent auditor’s report. This is not merely an earnings summary (ER) nor an announcement of report publication (RPA), but a comprehensive interim report on quarterly results (albeit including year‐end numbers) as required under SEBI Regulation 33. Therefore, it best fits the definition of an Interim / Quarterly Report. FY 2026
2026-05-19 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.